Barr in Deal With Organon, Savient to Buy Mircette, Settle Patent Suit

Drug Industry Daily
KEYWORDS OTC / Patents
A A

Barr Pharmaceuticals has entered into a preliminary agreement with Organon and Savient Pharmaceuticals to buy rights to contraceptive Mircette. The agreement, pending FTC approval, effectively ends a drawn-out patent suit over Barr’s generic version of the drug.

To View This Article:

Login

Subscribe To Drug Industry Daily